Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis

Annals of Clinical Biochemistry

Volumn 49, Issue 1, 2012, Pages 68-74

  Shima, Kenji ^a   Chujo, Keiko ^a   Yamada, Mayumi ^a   Komatsu, Machiko ^a   Noma, Yoshihiko ^a   Mizuguchi, Takashi ^a  

^a Kawashima Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ERYTHROCYTE LIFESPAN; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; GLOMERULAR FILTRATION RATE; HALF-LIFE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; REGRESSION ANALYSIS; RENAL DIALYSIS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 84855928823     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2011.011161     Document Type: Article

References (28)

1. DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86
2. Stratton IM, Adler AI, Neil HA, et al. Association of glycemia with macrovascular and microvascular complications of type2 diabetes (UKPDS35): prospective observational study. BMJ 2000;321:405-12
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-9
4. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72
5. Lippi G, Targher G. Glycated hemoglobin (HbA1c): old dogmas, a new perspective? Clin Chem Lab Med 2010;48:609-14
6. Chujo K, Shima K, Tada H, Oohashi T, Minakuchi J, Kawashima S. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Invest 2006;53:223-8
7. Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007;18:896-903
8. Peacock JP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycated albumin and haemoglobin A1c in diabetic subjects on hemodialysis. Kidney Int 2008;73:1062-8
9. Koga M, Murai J, Saito H, Otsuka M, Kasayama M. Evaluation of the glycated albumin/HbA1c ratio by stage of diabetic nephropathy. Diabet Int 2011;2:141-5
10. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007;11:156-63
11. Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabet Inte 2010;1:2-20
12. Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S. An enzymatic method for the measurement of glycated albumin in biological sampler. Clin Chim Act 2002;326:61-71
13. Stocchi A, Schwartz S, Ellefson M, Engel RR, Medina A, Levitt MD. A simple carbon monoxide breath test to estimate erythrocyte turnover. J Lab Clin Med 1992;120:392-9
14. Okada T, Nakao T, Matsumoto H, et al. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Intern Med 2011;50:23-9
15. Nakao T, Matsumoto H, Okada T, et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 1998;37:826-30
16. Filzgiblons JF, Koter D, Jones RT. Red cell age-related changes of hemoglobins A1a+b and A1c in normal and diabetic subjects. J Clin Invest 1976;58:820-4
17. Knzisnik C, Lukac-Bajalo J. Glycosylated hemoglobin in fractions of erythrocytes of different ages. J Endocrinol Invest 1993;16:495-8
18. Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284-91
19. Bonomini M, Sirolli V, Reale M, Arduini A. Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes. Am J Kidney Dis 2001;37:807-14
20. Stenvinkel P. The role of inflammation in the anemia of end-stage renal disease. Nephrol Dial Transplant 2001;16(Suppl 7):36-40
21. Massry SG. Pathogenesis of the anemia of uremia: role of secondary hyperparathyroidism. Kidney Int 1983;16(Suppl 24):204-7
22. Polenakovic M, Sikole A. Is erythropoietin a survival factor for red blood cell? J Am Soc Nephrol 1996;71:1178-82
23. Loge JP, Lange RD, Moore CV. Characterization of the anemia associated with chronic renal failure. Am J Med 1958;24:4-18
24. Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989;35:134-48
25. Ly J, Marticorena R, Donnally S. Red blood cell survival in chronic renal failure. Am J Kidney Dis 2004;44:715-9
26. Uehlinger DE, Gotch FA, Sheiner LB. A pharmacodynamic model of erythropoietin therapy for uremic anemia. Clin Pharmacol Ther 1992;51:76-89
27. Kruse A, Uehlinger DE, Gotch F, Kotanko P, Levin NW. Red blood cell lifespan, erythropoiesis and hemoglobin control. In: Ronco C, Cruz DM, eds. Hemodialysis - From Basic Research to Clinical Trials. Vol. 161. Basel: Karger, 2008:247-58
28. Virtae MA, Furne JK, Nuttal FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004;27:931-5